Hence, modulation of the function of UNC93B1, syntenin-1, the MHCII-associated invariant chain or αvβ3 integrin to affect TLR7 trafficking mechanisms in SLE B cells is an interesting strategy for treatment (111, 132, 135). This evidence concerns the gene TLR7 and systemic lupus erythematosus.